Series B Round

Skin Analytics is a London-based medtech company founded in 2012, focused on improving skin cancer diagnosis through innovative AI technology. The company collaborates with the NHS to develop world-leading skin cancer pathways using its proprietary AI solutions. With a mission to build a future where nobody dies of skin cancer, Skin Analytics aims to expand its AI platform beyond skin cancer and enhance its teledermatology services. The recent funding will be utilized to further develop their AI technology and expand their market reach globally. The funding round was led by Intrepid Growth Partners, a venture capital firm known for investing in innovative healthtech solutions.